Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acorda Therapeutics
Pharma
Merz to expand and hunt for more deals after closing Inbrija buy
Equipped with two approved meds from Acorda Therapeutics, Germany’s Merz Therapeutics is kicking its specialty neurology ambitions into high gear.
Fraiser Kansteiner
Jul 11, 2024 4:08pm
Acorda fights on with new Inbrija ad ahead of bankruptcy sale
Jun 3, 2024 11:52am
Acorda files for bankruptcy, inks $185M asset deal to Merz
Apr 9, 2024 8:29am
Fighting talk: Acorda gets combative in new Parkinson's campaign
Aug 3, 2023 8:00am
Acorda slashes jobs again as generics hamper sales of MS drug
Sep 9, 2021 12:31pm
Sunovion launches Parkinson's med Kynmobi into a crowded market
Oct 14, 2020 7:35am